Pharmaceutical Executive-01-01-2017

Pharmaceutical Executive

Path of Uncertainty: Pharm Exec’s 2017 Industry Forecast

February 03, 2017

Features

37

1

The populist-driven shifts trumpeted from the US to the EU leaves plenty of question marks when trying to size up the trajectory of the global pharma industry. One certainty, however, will be change.

Biopharma Change Agent: Belén Garijo

January 23, 2017

Features

37

1

Pharm Exec speaks with Spanish-born Belén Garijo, CEO of Merck KGaA, Darmstadt, Germany’s healthcare business, who shares her steady-eyed approach in transforming a traditional pharma unit focused on small molecules for chronic disease to a high-tech specialty producer of immunotherapy drugs for rare cancers.

Pharma and Biotech Markets: Challenges and Opportunities

January 18, 2017

Features

37

1

With the soaring valuations of companies in the public and M&A markets now seemingly a distant memory, the challenge for pharma and biotech business will be choosing just the right overall mix of M&A, licensing, and partnering.

Country Report: Philippines

January 01, 2017

Special Sponsored Section

37

1

This sponsored supplement was produced by Focus ReportsProject Publisher: Mariuca GeorgescuProject Director: Carla Verdera MateuCoordinators: Brandon Mourich & Julija LukaityteProject Assistants: Zoë BerginSenior Editor: Louis HaynesEditor: Patrick Burton

Pharmaceutical Executive, January 2017 Issue (PDF)

January 01, 2017

Issue PDF

37

1

Click the title above to open the Pharmaceutical Executive January 2017 issue in an interactive PDF format.